Basal markers and prognosis in luminal breast cancer

被引：0
作者：
Monica J. Engstrøm
Marit Valla
Anna M. Bofin
机构：
[1] Norwegian University of Science and Technology,Department of Public Health and Nursing, Faculty of Medicine and Health Sciences
[2] Norwegian University of Science and Technology,Department of Laboratory Medicine, Children’s and Women’s Health, Faculty of Medicine and Health Sciences
[3] St. Olav’s Hospital,Department of Breast and Endocrine Surgery
来源：
Breast Cancer Research and Treatment | 2017年 / 163卷
关键词：
Breast cancer; Luminal subtypes; Basal markers; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：207 / 217
页数：10
相关论文
共 50 条
[21]   Actionable pharmacogenetic markers for prediction and prognosis in breast cancer [J].
Keith Sacco ;
Godfrey Grech .
EPMA Journal, 2015, 6
[22]   Actionable pharmacogenetic markers for prediction and prognosis in breast cancer [J].
Sacco, Keith ;
Grech, Godfrey .
EPMA JOURNAL, 2015, 6
[23]   How different are luminal A and basal breast cancers? [J].
Bertucci, Francois ;
Finetti, Pascal ;
Cervera, Nathalie ;
Charafe-Jauffret, Emmanuelle ;
Buttarelli, Max ;
Jacquemier, Jocelyne ;
Chaffanet, Max ;
Maraninchi, Dominique ;
Viens, Patrice ;
Birnbaum, Daniel .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (06) :1338-1348
[24]   Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer [J].
Li, Shi-Yang ;
Hammarlund, Jan A. ;
Wu, Gang ;
Lian, Jia-Wen ;
Howell, Sacha J. ;
Clarke, Robert B. ;
Adamson, Antony D. ;
Goncalves, Catia F. ;
Hogenesch, John B. ;
Anafi, Ron C. ;
Meng, Qing-Jun .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (07)
[25]   Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype [J].
Bae, Soo Youn ;
Jung, Seung Pil ;
Jung, Eun Sung ;
Park, Sung Min ;
Lee, Se Kyung ;
Yu, Jong Han ;
Lee, Jeong Eon ;
Kim, Seok Won ;
Nam, Seok Jin .
ONCOLOGY, 2018, 95 (03) :163-169
[26]   Combination of SIRTI and Src overexpression suggests poor prognosis in luminal breast cancer [J].
Tan, Jie ;
Liu, Yuyin ;
Maimaiti, Yusufu ;
Wang, Changwen ;
Yan, Yu ;
Zhou, Jing ;
Ruan, Shengnan ;
Huang, Tao .
ONCOTARGETS AND THERAPY, 2018, 11 :2051-2061
[27]   Stratification of Prognosis by Biological Features Following Neoadjuvant Chemotherapy in Luminal Breast Cancer [J].
Yamamoto, Shinya ;
Chishima, Takashi ;
Shibata, Yukako ;
Inoue, Shiori ;
Harada, Fumi ;
Takeuchi, Hideki ;
Yamada, Akimitsu ;
Narui, Kazutaka ;
Endo, Itaru .
IN VIVO, 2022, 36 (02) :859-864
[28]   MLF1IP is correlated with progression and prognosis in luminal breast cancer [J].
Huang, Du-Ping ;
Luo, Rong-Cheng .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 477 (04) :923-926
[29]   The Potential Role of Hedgehog Signaling in the Luminal/Basal Phenotype of Breast Epithelia and in Breast Cancer Invasion and Metastasis [J].
Flemban, Arwa ;
Qualtrough, David .
CANCERS, 2015, 7 (03) :1863-1884
[30]   Association between mammographic density and basal-like and luminal A breast cancer subtypes [J].
Razzaghi, Hilda ;
Troester, Melissa A. ;
Gierach, Gretchen L. ;
Olshan, Andrew F. ;
Yankaskas, Bonnie C. ;
Millikan, Robert C. .
BREAST CANCER RESEARCH, 2013, 15 (05)
12345